Literature DB >> 35288791

Rectal neuroendocrine neoplasms: what the radiologists should know.

Mayur Virarkar1, Dheeraj R Gopireddy2, Ajaykumar C Morani3, Ahmad Alkhasawneh4, Sergio Piotr Klimkowski3, Sindhu Kumar2, Chandana Lall2, Priya Bhosale3.   

Abstract

Neuroendocrine neoplasms of the rectum (R-NENs) are rare; however, their incidence has increased almost threefold in the last few decades. Imaging of R-NENs includes two primary categories: anatomic/morphologic imaging comprised of endoscopic ultrasound (EUS), computed tomography (CT), magnetic resonance imaging (MRI), and functional/molecular imaging comprising of planar scintigraphy, single-photon emission computed tomography (SPECT), and positron emission tomography (PET). The management depends on stage, dimension, atypical features, histological grade, and lymphovascular invasion (LVI). Low-risk local R-NENs can be resected endoscopically, and high-risk or locally advanced neoplasms can be treated with radical surgery and lymphadenectomy and/or chemoradiation. The review article focuses on imaging illustrations and discusses applications of different imaging modalities in diagnosing and managing R-NENs.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Carcinoid; Neoplasm; Neuroendocrine; Rectum

Year:  2022        PMID: 35288791     DOI: 10.1007/s00261-022-03474-9

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  100 in total

1.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations.

Authors:  Anders Sundin; Marie-Pierre Vullierme; Gregory Kaltsas; Ursula Plöckinger
Journal:  Neuroendocrinology       Date:  2009-08-28       Impact factor: 4.914

Review 2.  Neuroendocrine tumours: the role of imaging for diagnosis and therapy.

Authors:  Martijn van Essen; Anders Sundin; Eric P Krenning; Dik J Kwekkeboom
Journal:  Nat Rev Endocrinol       Date:  2013-12-10       Impact factor: 43.330

Review 3.  Colonic and rectal NET's.

Authors:  Dalvinder Mandair; Martyn E Caplin
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

4.  Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management.

Authors:  Dushyant V Sahani; Pietro A Bonaffini; Carlos Fernández-Del Castillo; Michael A Blake
Journal:  Radiology       Date:  2013-01       Impact factor: 11.105

Review 5.  Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Mauro Cives; Jonathan R Strosberg
Journal:  CA Cancer J Clin       Date:  2018-10-08       Impact factor: 508.702

Review 6.  Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?

Authors:  Satya Das; Arvind Dasari
Journal:  Curr Oncol Rep       Date:  2021-03-14       Impact factor: 5.075

Review 7.  Imaging of neuroendocrine tumors: A pictorial review of the clinical value of different imaging modalities.

Authors:  Ali Pirasteh; Petra Lovrec; Lisa Bodei
Journal:  Rev Endocr Metab Disord       Date:  2021-03-30       Impact factor: 9.306

8.  Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms.

Authors:  Emanuele Leoncini; Paolo Boffetta; Michail Shafir; Katina Aleksovska; Stefania Boccia; Guido Rindi
Journal:  Endocrine       Date:  2017-03-16       Impact factor: 3.633

9.  Efficacy and safety of hybrid endoscopic submucosal dissection compared with endoscopic submucosal dissection for rectal neuroendocrine tumors and risk factors associated with incomplete endoscopic resection.

Authors:  Xiang-Yao Wang; Ning-Li Chai; En-Qiang Linghu; Hui-Kai Li; Ya-Qi Zhai; Xiu-Xue Feng; Wen-Gang Zhang; Jia-Le Zou; Long-Song Li; Jing-Yuan Xiang
Journal:  Ann Transl Med       Date:  2020-03

10.  Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections.

Authors:  Osayande Osagiede; Elizabeth Habermann; Courtney Day; Emmanuel Gabriel; Amit Merchea; Riccardo Lemini; Iktej S Jabbal; Dorin T Colibaseanu
Journal:  J Gastrointest Oncol       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.